| 1 |
Die pharmakologische/pharmazeutische Visite in der Intensivmedizin |
|
|
| H. Hilgarth,M. Baehr,S. Kluge,C. König |
|
| Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Prevalence of drug–drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management |
|
|
| Audrey Bellesoeur,Ithar Gataa,Anne Jouinot,Sarah El Mershati,Anne-Catherine Piketty,Camille Tlemsani,David Balakirouchenane,Anthia Monribot,Michel Vidal,Rui Batista,Sixtine de Percin,Clémentine Villeminey,Jérôme Alexandre,François Goldwasser,Benoit Blanchet,Pascaline Boudou-Rouquette,Audrey Thomas-Schoemann |
|
| Cancer Chemotherapy and Pharmacology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Management of drug-disease interactions: a best practice from the Netherlands |
|
|
| Maaike M. E. Diesveld,Suzanne de Klerk,Pieter Cornu,Dorothea Strobach,Katja Taxis,Sander D. Borgsteede |
|
| International Journal of Clinical Pharmacy. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Determination of potential drug–drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a retrospective observational study |
|
|
| Afraa Abbas, Samaher Al-Shaibi, Sowndramalingam Sankaralingam, Ahmed Awaisu, Vyas S. Kattezhathu, Supakit Wongwiwatthananukit, Yaw B. Owusu |
|
| International Journal of Clinical Pharmacy. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study |
|
|
| John E. Hughes,Veronica Russo,Caroline Walsh,Enrica Menditto,Kathleen Bennett,Caitriona Cahir |
|
| Drugs & Aging. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Differences in Information Accessed in a Pharmacologic Knowledge Base Using a Conversational Agent vs Traditional Search Methods |
|
|
| Anita M. Preininger,Bedda L. Rosario,Adam M. Buchold,Jeff Heiland,Nawshin Kutub,Bryan S. Bohanan,Brett South,Gretchen P. Jackson |
|
| International Journal of Medical Informatics. 2021; : 104530 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
The screening and evaluation of potential clinically significant HIV drug combinations against the SARS-CoV-2 virus |
|
|
| Draško Tomic,Davor Davidovic,Attila Marcel Szasz,Melinda Rezeli,Boris Pirkic,Jozsef Petrik,Vesna Bacic Vrca,Vladimir Jandel,Tomislav Lipic,Karolj Skala,Josip Mesaric,Marija Milkovic Periša,Zorislav Šojat,Branka Medved Rogina |
|
| Informatics in Medicine Unlocked. 2021; : 100529 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Prescription patterns of direct oral anticoagulants and concomitant use of interacting medications in the Netherlands |
|
|
| R. E. Harskamp,J. C. L. Himmelreich,G. W. M. Wong,M. Teichert |
|
| Netherlands Heart Journal. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults |
|
|
| Matthew Sugidono,Mimi Lo,Rebecca Young,Kimberly Rosario,Yoonie Jung,Chiung-Yu Huang,Ying Sheng,Li-Wen Huang,Rebecca L. Olin |
|
| Transplantation and Cellular Therapy. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Bradyarrhythmias in Cardio-Oncology |
|
|
| Marta Fonseca, Evaline Cheng, Duc Do, Shouvik Haldar, Shelby Kutty, Eric H. Yang, Arjun K. Ghosh, Avirup Guha |
|
| South Asian Journal of Cancer. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Risk factors for potential drug–drug interactions in patients with myasthenia gravis |
|
|
| Dejan Z. Aleksic,Miloš N. Milosavljevic,Srdan M. Stefanovic,Andriana Bukonjic,Jovana Z. Milosavljevic,Slobodan M. Jankovic,Ivo Božovic,Stojan Peric,Dragana Lavrnic |
|
| Neurological Research. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Prevalence and characteristics of drug-drug interactions among hospitalised patients in the Capital Region of Denmark |
|
|
| Hans Kristian Rĺket Pedersen, Anne Mette Skov Sřrensen, Astrid Blicher Schelde, Martin Erik Nyeland, Espen Jimenez-Solem |
|
| Adverse Drug Reaction Bulletin. 2021; Publish Ah |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
A Cross-Sectional Study on Single-Day Use of Proton Pump Inhibitors in Tertiary Care Hospitals of South India |
|
|
| Zabiuddin Ahad M,Alekhya Lavu,Maria Ansari,Raviraj Acharya V,Rajesh Vilakkathala |
|
| Hospital Pharmacy. 2021; 56(2): 109 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Novel Drug Interaction index and Risk of Mortality in Older Patients With Atrial Fibrillation Receiving Non Vitamin K Oral Anticoagulants (NOEL Drug) |
|
|
| Ibrahim Ersoy |
|
| Clinical and Applied Thrombosis/Hemostasis. 2021; 27: 1076029621 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics |
|
|
| John B Bossaer, Danielle Eskens, Austin Gardner |
|
| Journal of Oncology Pharmacy Practice. 2021; : 1078155220 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis |
|
|
| Niklas Frahm, Melanie Peters, Jörg Bätzing, David Ellenberger, Manas K. Akmatov, Judith Haas, Paulus S. Rommer, Alexander Stahmann, Uwe K. Zettl, Jakob Holstiege |
|
| Therapeutic Advances in Neurological Disorders. 2021; 14: 1756286421 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data |
|
|
| Levin Thomas, Sumit Raosaheb Birangal, Rajdeep Ray, Sonal Sekhar Miraj, Murali Munisamy, Muralidhar Varma, Chidananda Sanju S.V., Mithu Banerjee, Gautham G. Shenoy, Mahadev Rao |
|
| Therapeutic Advances in Drug Safety. 2021; 12: 2042098621 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States |
|
|
| Marwan Sheikh-Taha,Myriam Asmar |
|
| BMC Geriatrics. 2021; 21(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Potential drug-drug interactions with psychotropic drugs in paediatric inpatients: A cross-sectional study |
|
|
| Nadir Yalçin,Nesligül Özdemir,Halime Tuna Çak Esen,Sadriye Ebru Çengel Kültür,Kutay Demirkan |
|
| International Journal of Clinical Practice. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
The prevalence of potential drug–drug interactions in adults with intellectual disability |
|
|
| M. McMahon,C. Hatton,D. L. Bowring,C. Hardy,N. J. Preston |
|
| Journal of Intellectual Disability Research. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Prevention and management of physical health conditions in adults with severe mental disorders: WHO recommendations |
|
|
| Petra C. Gronholm,Neerja Chowdhary,Corrado Barbui,Jayati Das-Munshi,Kavitha Kolappa,Graham Thornicroft,Maya Semrau,Tarun Dua |
|
| International Journal of Mental Health Systems. 2021; 15(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study |
|
|
| Zarka Akbar,Sundas Rehman,Asad Khan,Amjad Khan,Muhammad Atif,Nafees Ahmad |
|
| Journal of Pharmaceutical Policy and Practice. 2021; 14(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Potentially Inappropriate Medication and Associated Factors Among Older Patients with Chronic Coronary Syndrome at Hospital Discharge in Beijing, China |
|
|
| Mei Zhao,Jun-Xian Song,Fang-Fang Zheng,Lin Huang,Yu-Fei Feng |
|
| Clinical Interventions in Aging. 2021; Volume 16: 1047 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Polypharmacy and Potential Drug–Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study |
|
|
| Monica Hermann,Nina Carstens,Lars Kvinge,Astrid Fjell,Marianne Wennersberg,Kjersti Folleso,Knut Skaug,Ake Seiger,Berit Seiger Cronfalk,Anne-Marie Bostrom |
|
| Journal of Multidisciplinary Healthcare. 2021; Volume 14: 589 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson’s Disease |
|
|
| Niklas Frahm,Michael Hecker,Uwe Klaus Zettl |
|
| Current Pharmaceutical Design. 2021; 27 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders |
|
|
| Stefania Zampatti,Carlo Fabrizio,Michele Ragazzo,Giulia Campoli,Valerio Caputo,Claudia Strafella,Clelia Pellicano,Raffaella Cascella,Gianfranco Spalletta,Laura Petrosini,Carlo Caltagirone,Andrea Termine,Emiliano Giardina |
|
| Journal of Personalized Medicine. 2021; 11(9): 851 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN® System Comprehensive Approach |
|
|
| Michela Roberto,Alessandro Rossi,Martina Panebianco,Leda Marina Pomes,Giulia Arrivi,Debora Ierinň,Maurizio Simmaco,Paolo Marchetti,Federica Mazzuca |
|
| Pharmaceuticals. 2021; 14(1): 67 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
Comparing Potential Drug–Drug Interactions in Companion Animal Medications Using Two Electronic Databases |
|
|
| Tussapon Boonyarattanasoonthorn,Phisit Khemawoot,Anusak Kijtawornrat |
|
| Veterinary Sciences. 2021; 8(4): 60 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
Assessing Consistency of Drug-Drug Interaction-Related Information Across Various Drug Information Resources |
|
|
| Atiqulla Shariff,Sathvik Belagodu Sridhar,Neelu Farhath Abdullah Basha,Shamma Sulaiman Hasan Bin Taleth Alshemeil,Noora Adel Ahmed Aljallaf Alzaabi |
|
| Cureus. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
Investigation of Potential Drug-Drug Interactions in an Intensive Care Unit Using Lexicomp Drug Interactions |
|
|
| Hiroki Tateishi, Daisuke Miyazu, Takao Goto, Michiko Mukae, Yoshitoyo Miyauchi, Yoichi Koda, Hirokazu Tanaka, Masaaki Hirakawa |
|
| Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 2020; 46(10): 576 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 31 |
The pharmacoepidemiology of potential drug-drug interactions in patients with psychiatric disorders |
|
|
| O. O. Kirilochev,A. R. Umerova |
|
| Kachestvennaya klinicheskaya praktika. 2020; (3): 85 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 32 |
Prevalence of Potential Drug–Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital |
|
|
| Gracia Santos-Díaz,Ana María Pérez-Pico,Miguel Ángel Suárez-Santisteban,Vanesa García-Bernalt,Raquel Mayordomo,Pedro Dorado |
|
| Pharmaceutics. 2020; 12(8): 713 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 33 |
Prevalence, predictors and outcomes of potential drug-drug interactions in left ventricular failure: considerable factors for quality use of medicines |
|
|
| Inamul Haq,Mohammad Ismail,Fahadullah Khan,Qasim Khan,Zahid Ali,Sidra Noor |
|
| Brazilian Journal of Pharmaceutical Sciences. 2020; 56 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 34 |
Patterns and characteristics of polypharmacy among elderly residents in Danish nursing homes |
|
|
| Jacob Astorp,Mimoza Gjela,Pernille Jensen,Rasmus D Bak,Parisa Gazerani |
|
| Future Science OA. 2020; : FSO590 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 35 |
Performance Assessment of Software to Detect and Assist Prescribers with Antimicrobial Drug Interactions: Are all of them Created Equal? |
|
|
| Elena Morte-Romea,Pilar Luque-Gómez,Mercedes Arenere-Mendoza,Jose Luis Sierra-Monzón,Ana Camón Pueyo,Galadriel Pellejero Sagastizabal,Guillermo Verdejo Muńoz,David Sánchez Fabra,José Ramón Pańo-Pardo |
|
| Antibiotics. 2020; 9(1): 19 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 36 |
Potential Drug interactions with Drugs used for Bipolar Disorder: A
Comparison of 6 Drug Interaction Database Programs |
|
|
| Scott Monteith,Tasha Glenn,Michael Gitlin,Michael Bauer |
|
| Pharmacopsychiatry. 2020; 53(05): 220 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 37 |
Assessing Drug-Drug Interaction Potential among Patients Admitted to Surgery Departments in Three Palestinian Hospitals |
|
|
| Abdullah K. Rabba,Ayeshe M. Abu Hussein,Bayan K. Abu Sbeih,Somaya I. Nasser |
|
| BioMed Research International. 2020; 2020: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 38 |
Drug interactions of natural supplements in dermatology: a review |
|
|
| Edward K. Hadeler,Andrea D. Maderal |
|
| International Journal of Dermatology. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 39 |
Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy |
|
|
| Mohammad Ismail,Sehrash Khan,Fahadullah Khan,Sidra Noor,Hira Sajid,Shazia Yar,Irum Rasheed |
|
| BMC Cancer. 2020; 20(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 40 |
Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness |
|
|
| Jayati Das-Munshi,Maya Semrau,Corrado Barbui,Neerja Chowdhary,Petra C. Gronholm,Kavitha Kolappa,Dzmitry Krupchanka,Tarun Dua,Graham Thornicroft |
|
| BMC Psychiatry. 2020; 20(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 41 |
Enzymatic deinduction phenomenon and clinical implications with a focus on direct-acting oral anticoagulants |
|
|
| Jennifer L. Cole |
|
| Blood Coagulation & Fibrinolysis. 2020; 31(4): 283 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 42 |
Chronic Obstructive Pulmonary Disease: A palliative medicine review of the disease, its therapies and drug interactions |
|
|
| Andrea Weiss,Sandra Porter,Dmitry Rozenberg,Erin O’Connor,Tiffany Lee,Meyer Balter,Kirsten Wentlandt |
|
| Journal of Pain and Symptom Management. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 43 |
Optimierung des Interaktionsmanagements zur Prävention potenzieller schwerwiegender Arzneimittelinteraktionen bei onkologischen Patienten |
|
|
| J. Rosentreter,A.-K. Engl,L. Wojnowski,M. Kühn,T. Wölfel,I. Krämer |
|
| best practice onkologie. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 44 |
Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs |
|
|
| M. Castro-Manzanares,F. do Pazo-Oubińa,R. M. Rodríguez-Rincón |
|
| International Journal of Clinical Pharmacy. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 45 |
Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients |
|
|
| Martin Klietz,Stephan Greten,Florian Wegner,Günter U. Höglinger |
|
| Drugs & Aging. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 46 |
Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort |
|
|
| Guillaume Beinse,Delphine Reitter,Lauriane Segaux,Muriel Carvahlo-Verlinde,Benoit Rousseau,Christophe Tournigand,Tristan Cudennec,Marie Laurent,Pascaline Boudou-Rouquette,Elena Paillaud,Florence Canouď-Poitrine,Philippe Caillet |
|
| Journal of Geriatric Oncology. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 47 |
The prevalence and severity of potential drug- drug interactions among polypharmacy patients in Jordan |
|
|
| Mohammad B. Nusair,Sayer I. Al-azzam,Rasha. M. Arabyat,Haneen A. Amawi,Karem H. Alzoubi,Asma Rabah |
|
| Saudi Pharmaceutical Journal. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 48 |
A comparison of potential psychiatric drug interactions from six drug interaction database programs |
|
|
| Scott Monteith,Tasha Glenn |
|
| Psychiatry Research. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 49 |
Prevalence and trend of potential drug–drug interaction among children with depression in U.S. outpatient settings |
|
|
| L. Leanne Lai,Goar Alvarez,Linh Dang,Dung Vuong,Vy Ngo,Yailin Jo,Leroy Koh |
|
| Journal of Pharmaceutical Health Services Research. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 50 |
Comparison of potential drug-drug interactions with metabolic syndrome medications detected by two databases |
|
|
| Bovornpat Suriyapakorn,Pun Chairat,Suwanan Boonyoprakarn,Pimonwan Rojanarattanangkul,Wassana Pisetcheep,Natthaphon Hunsakunachai,Pornpun Vivithanaporn,Supakit Wongwiwatthananukit,Phisit Khemawoot,Masaki Mogi |
|
| PLOS ONE. 2019; 14(11): e0225239 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 51 |
Safety of psychopharmacotherapy: a clinical and pharmacological approach |
|
|
| O. O. Kirilochev,A. R. Umerova |
|
| Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2019; 119(10): 127 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 52 |
Yogun Bakim Hastalarinda Antibiyotiklerin Diger Ilaçlarla Etkilesimlerinin Degerlendirilmesi |
|
|
| EMRE KARA,Kamer Tecen-Yücel,Nesligül Özdemir,Ahmet Çagkan Inkaya,Aygin Bayraktar-Ekincioglu,Kutay Demirkan,Serhat Ünal |
|
| STED / Sürekli Tip Egitimi Dergisi. 2019; : 404 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 53 |
Prediction of Drug-Drug Interactions Related to Inhibition or Induction of Drug-Metabolizing Enzymes |
|
|
| Alexander V. Dmitriev,Alexey A. Lagunin,Dmitry ?. Karasev,Anastasia V. Rudik,Pavel V. Pogodin,Dmitry A. Filimonov,Vladimir V. Poroikov |
|
| Current Topics in Medicinal Chemistry. 2019; 19(5): 319 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 54 |
Risk Factors for the Occurrence of Potential Drug-drug Interactions in Surgical Patients |
|
|
| Miloš N. Milosavljevic,Aleksandar G. Kocovic,Slobodan M. Jankovic,Dragce M. Radovanovic,Slobodan S. Milisavljevic,Srdan M. Stefanovic |
|
| Serbian Journal of Experimental and Clinical Research. 2019; 0(0) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 55 |
Clozapine Patients at the Interface between Primary and Secondary Care |
|
|
| Marita Barrett,Anna Keating,Deirdre Lynch,Geraldine Scanlon,Mary Kigathi,Fidelma Corcoran,Laura Sahm |
|
| Pharmacy. 2018; 6(1): 19 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 56 |
Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives? |
|
|
| Sidra Noor,Mohammad Ismail,Iqbal Haider,Faiza Khadim |
|
| Annals of Hepatology. 2018; 17(6): 1001 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 57 |
Risk factors for potential drug-drug interactions in intensive care unit patients |
|
|
| Slobodan M. Jankovic,Ana V. Pejcic,Miloš N. Milosavljevic,Valentina D. Opancina,Nikola V. Pešic,Tamara T. Nedeljkovic,Goran M. Babic |
|
| Journal of Critical Care. 2018; 43: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 58 |
Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro |
|
|
| Leibin Shen,Jun Wang,Yongdong Yi,Chenmin Ye,Rongrong Wang,Guojun Xia,Chengyang Yu,Fuyang Tu,Jingxuan Xu,Zhiqiang Zheng |
|
| Drug Testing and Analysis. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 59 |
Therapeutisches Drug-Monitoring (TDM) in der Praxis |
|
|
| Andreas von Heydwolff |
|
| psychopraxis. neuropraxis. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 60 |
E-Health und die Realität – was sehen wir heute schon in der Klinik? |
|
|
| H. Gehring,K. Rackebrandt,M. Imhoff |
|
| Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 61 |
Prevalence of QT interval prolonging drug–drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study |
|
|
| Qasim Khan,Mohammad Ismail,Iqbal Haider,Fahadullah Khan |
|
| International Journal of Clinical Pharmacy. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 62 |
Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study |
|
|
| Mohammad Ismail,Sana Aziz,Sidra Noor,Iqbal Haider,Faryal Shams,Inamul Haq,Faiza Khadim,Qasim Khan,Fahadullah Khan,Muhammad Asif |
|
| Journal of Critical Care. 2017; 40: 243 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
